Diagnos Laboratorium Utama Tbk. vs Surya Citra Media Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp224 (market cap 310.75B, 963.6K 24h volume), while Surya Citra Media Tbk. trades at Rp206 (market cap 15.24T, 16.66M 24h volume). The key difference: Surya Citra Media Tbk. is far larger — about 49× Diagnos Laboratorium Utama Tbk.'s market cap, and Surya Citra Media Tbk. is more actively traded (16.66M versus 963.6K). Which is the better fit depends on your goals.
| DGNS | SCMA | |
|---|---|---|
Market Cap | 310.75B | 15.24T |
Volume | 963.6K | 16.66M |
Lot | 9.64K | 166.58K |
Turnover | 217.67M | 3.44B |
Average Price | 225.89 | 206.52 |
Value | 217.67M | 3.44B |
Indicative Equilibrium Price | 226 | 206 |
Indicative Equilibrium Volume | 1K | 13.07K |
Trailing returns across standard periods
Latest headlines on both assets
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →PT Surya Citra Media Tbk (the Company) formerly PT. Surya Citra Televisi, or popularly known as SCTV, started operations in Surabaya the capital of East Java in 1990 as a regional television station to server the province and the island of Bali. In 1993, pursuant to moving its headquarters to Jakarta, SCTV began broadcasting nationwide. In 29 Jan 1999 PT Cipta Aneka Selaras was established at jakarta and the company changed to PT Surya Citra Media at 31 Dec 2001. PT Elang Mahkota Teknologi Tbk is the ultimate parent company of the Company and Subsidiaries.
Read more on SCMA →